Your patient is in their seventh round of CPR. Three shocks, three rounds of epi, amio is in, and the monitor keeps mocking you with that same coarse fibrillatory waveform. Someone yells "grab another defibrillator!" and a tech sprints down the hall. You pause. Is this evidence-based medicine, or are we about to do something dramatic so we feel less helpless?
This is the refractory ventricular fibrillation rabbit hole, and it's worth knowing exactly what the evidence supports before you start stacking machines.
Defining the Problem: What Counts as Refractory VF?
Most working definitions land in the same neighborhood: VF or pulseless VT that persists after three consecutive defibrillation attempts, adequate CPR, epinephrine, and an antiarrhythmic (amiodarone or lidocaine). It's not common, but it's not rare either. Roughly 0.5 to 0.6% of all cardiac arrests present as shock-refractory VF, and these patients have historically had abysmal outcomes when you just keep doing the same thing harder.
The biology matters here. Persistent VF after multiple shocks often reflects either a fixed substrate (ischemia, scar) that keeps reinitiating the rhythm, or a defibrillation vector that simply isn't depolarizing enough myocardium to terminate the circuit. That second piece is the lever the new strategies try to pull.
The Three Strategies
When people say "dual defib," they often conflate two distinct things. Let's separate them.
Standard defibrillation is what you already do: pads in anterolateral position, single defibrillator, single shock per cycle. Fine for most VF. Not enough for the subset that keeps coming back.
Vector-change defibrillation (VC) keeps a single defibrillator but moves the pads from anterolateral to anterior-posterior. One pad on the left precordium, the other between the scapulae or just left of the spine. Same energy, same machine, different current pathway through the heart. The theory: a fresh vector recruits myocardium the old vector wasn't reaching.
Double sequential external defibrillation (DSED) uses two defibrillators with two sets of pads, one set anterolateral and one set anterior-posterior. Both machines charged to max. The operator presses the shock buttons in rapid succession, ideally with less than a one-second delay, delivering near-simultaneous shocks across two different vectors. Higher cumulative energy, two pathways at once.
DSED is the showy one. Vector change is the quiet workhorse. Keep that distinction in your head.
What DOSE-VF Actually Showed
The DOSE-VF trial (Cheskes et al., NEJM 2022) is the headline study. Cluster randomized, crossover design, six Canadian paramedic services, 405 patients with refractory VF in the out-of-hospital setting. Three arms: standard defibrillation, vector change, and DSED.
The primary outcome was survival to hospital discharge. Numbers worth memorizing:
- Standard: 13.3% survival
- Vector change: 21.7% (RR 1.71 vs standard)
- DSED: 30.4% (RR 2.21 vs standard)
Secondary outcomes (termination of VF, ROSC, good neurologic outcome) trended the same direction. DSED came out on top, but vector change alone produced a clinically meaningful bump over standard care, with none of the logistical headaches of a second machine.
A few caveats before you order the second LIFEPAK. This was prehospital, EMS-delivered, with a specific protocol and training. The trial was stopped early due to COVID enrollment issues, which inflates effect size estimates. Confidence intervals are wide. And we still don't have a true head-to-head DSED versus vector change powered to detect a difference between those two, only their comparison against standard.
The REBEL EM synthesis makes this point clean: DSED is statistically better than standard, vector change is statistically better than standard, but DSED vs vector change is not a settled question. The headline-grabbing strategy may not be meaningfully superior to the simpler one.
The Contrarian Take: Don't Fetishize the Second Machine
Here's where we get a little spicy. DSED has captured the imagination of resuscitationists because it looks cool and feels like you're doing more. But more isn't always better in resuscitation. More usually means more chaos.
DSED requires a second defibrillator (not always available), a second operator trained to charge and discharge in sync, careful pad placement to avoid shunting current between the two machines, and tight coordination during a chaotic arrest. There are also case reports of defibrillator damage when shocks aren't well-synchronized, though no reported patient harm to date in trial data.
Vector change requires: moving the pads. That's it. Same machine, same operator, same energy. If you're in a community ED at 3 AM with one Zoll and a tech who's already drawing up the next round of epi, vector change is the move that actually fits your resources.
Our practical read: change the vector first. If you have a second machine and trained hands and you're still refractory after the vector change, escalate to DSED. Don't skip the simpler intervention to look like you're doing the fancy one.
How to Actually Do It at the Bedside
When you hit shock number three and the rhythm is still VF, that's your trigger to plan, not your trigger to panic.
For vector change: peel the anterolateral pads, place new pads anterior-posterior. Anterior pad over the left precordium, posterior pad to the left of the spine at the inferior angle of the scapula. Resume CPR while you reposition. Shock at max energy on the next rhythm check.
For DSED: keep the original anterolateral pads on. Add a second set anterior-posterior from a second defibrillator. Both machines charged to max. Designate one operator to call "shock, shock" and press both buttons in sequence as fast as possible, ideally under one second apart. Hands off the patient. Resume CPR immediately.
Don't forget the rest of the refractory VF playbook: think about reversible causes (especially ischemia, hyperkalemia, hypoxia), get the POCUS on during pulse checks, consider esmolol for sympathetic storm, and if your shop has it, start the ECPR conversation early. The defib strategy is one lever. It is not the only one.
The Bottom Line
- Refractory VF = persistent VF/pulseless VT after 3 shocks, epi, and an antiarrhythmic. Recognize it early.
- DOSE-VF showed both vector change (RR 1.71) and DSED (RR 2.21) beat standard defibrillation for survival to discharge. Both work.
- Change the vector first. Anterior-posterior pad placement is cheap, fast, and likely accounts for most of the benefit.
- Escalate to DSED if you have the resources and the patient remains refractory after a vector change. Don't skip steps to look cool.
- Don't forget the rest of the differential: ischemia, electrolytes, esmolol, ECPR. Defibrillation strategy is one tool in a bigger box.
Sources
- Cheskes S, et al. Defibrillation Strategies for Refractory Ventricular Fibrillation. N Engl J Med 2022;387:1947-1956. https://www.nejm.org/doi/full/10.1056/NEJMoa2207304
- Salim Rezaie. Alternate Defibrillation Strategies for Refractory Ventricular Fibrillation. REBEL EM. https://rebelem.com/double-defib/
- Cheskes S, et al. DOSE VF pilot study. Resuscitation 2020;150:178-184. https://www.resuscitationjournal.com/article/S0300-9572(20)30076-6/fulltext
- AHA Focused Update on ACLS. Circulation 2023. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001194
Disclaimer: The content on Against Medical Advice — including all podcast episodes, blog posts, and videos — is intended for educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Listening to or reading this content does not establish a doctor-patient relationship. Always consult a qualified healthcare provider for medical decisions. The views expressed are those of the hosts and do not represent their employers, residency programs, or affiliated institutions.